Clinical Trial Update: Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating different volumes of articaine for inferior alveolar nerve block in irreversible pulpitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Articaine (articaine)

Snippet

Sponsor: Armed Forces Institute of Dentistry, Pakistan | Conditions: Drug Effect, Pulpitis - Irreversible | Phase 2 | Status: COMPLETED